Imperial College London joins Parkinson's biomarker study; Edwards wins FDA nod for blood volume Dx monitor;

> Imperial College London will take part in a biomarker study funded by the Michael J. Fox Foundation for Parkinson's Research that is looking at the genetics of Parkinson's disease. Release

> Eurofins Scientific forked over $255 million to buy ViraCor-IBT Laboratories, a specialty diagnostic testing laboratory focused on the transplant market that services more than 550 institutional clients and over 4,000 affiliated clinicians across the U.S. Release

> The University of Milan and other Italian organizations have sealed some new cancer biomarker deals with a number of U.K. firms. Story (reg. req)

> Edwards Lifesciences ($EW) won FDA clearance for a new noninvasive diagnostic monitor for blood volume and flow to make sure post-surgery patients are getting enough oxygen in their organs and tissues. Item

> A new study points to plasma connective tissue growth factor as a possible asthma biomarker. Story

> Medical imaging company BioClinica ($BIOC) plans to showcase brain-imaging advances it has made in Alzheimer's disease clinical trials at an upcoming conference in Copenhagen. Release

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.